Episode 54
Biotech Hangout
00:00
The Astellus Data on Clotine 18 Antibodies
Josh Bigson: I think maybe people thought there would be some efficacy. Astellus data, Sorbotoxin app, which is the antibody against Claudine 18.2, gastric and gastric subagile junction cancers; plus chemo versus chemo alone. The OS benefit was only just 2.2 months increase, but it was highly significant according to ASCO plenary discussants. Daphne O'Brien: It's quite remarkable that to be going after this, it's a very difficult disease state to treat.
Transcript
Play full episode
